Cleared Traditional

K053360 - AEROLIFE ULTRASONIC NEBULIZER, MODEL P2C

K053360 is an FDA 510(k) clearance for AEROLIFE ULTRASONIC NEBULIZER, manufactured by Aerovectrx Corporation. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 111-day FDA review.

K053360 · Aerovectrx Corporation · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
111d
Days
Class 2
Risk

K053360 is an FDA 510(k) clearance for the AEROLIFE ULTRASONIC NEBULIZER, MODEL P2C. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Aerovectrx Corporation (Carmichael, US). The FDA issued a Cleared decision on March 23, 2006 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K053360

510(k) Number K053360 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 02, 2005
Decision Date March 23, 2006
Days to Decision 111 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 140d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 440
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K053360.
LC STAR WITH NASAL ADAPTER
K061381 · Pari Innovative Manufacturers, Inc. · Jun 2006
OMRON COMPRESSOR SYSTEMS, MODELS NE-C28,NE-C30
K060811 · Omron Healthcare, Inc. · May 2006
TREK S NEBULIZER COMPRESSOR
K060357 · Pari Innovative Manufacturers, Inc. · Apr 2006
LC SPRINT NEBULIZER
K060399 · Pari Innovative Manufacturers, Inc. · Mar 2006
AEROECLIPSE II BREATH ACTUATED NEBULIZER
K053605 · Trudell Medical Intl. · Feb 2006
EMG HANDLE NEBULIZER NB02 SERIES
K052438 · Emg Technology Co., Ltd. · Jan 2006